Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage |
Project Objective![]() |
Details |
---|---|---|---|---|---|---|
COVID-19 | iPS Cell | Cell delivery or targeting | UCSD |
![]() |
Tool/Resources/Bottleneck | |
Parkinson's Disease | iPS Cell | Cell processing & handling | Aspen Neuroscience | Research Insights, Tool/Resources/Bottleneck | ||
Amyotrophic Lateral Sclerosis, Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Cell imaging & tracking | UCSD |
![]() |
Research Insights | |
Embryonic Stem Cell | Cell processing & handling | Stanford |
![]() |
Research Insights | ||
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Research Insights | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
![]() |
Regulated Lab Test, Ready for Validation | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | UCSF |
![]() |
Regulated Lab Test, Ready for Validation | |
Hearing Loss | iPS Cell | Model system development | USC |
![]() |
Proof of Concept, Tool/Resources/Bottleneck | |
COVID-19 |
Embryonic Stem Cell, iPS Cell |
Gene-modified, donor cell therapy | COH |
![]() |
Proof of Concept | |
COVID-19 | iPS Cell | Model system development | UC Berkeley |
![]() |
Proof of Concept | |
Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Proof of Concept | |
Blood Disorders, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Proof of Concept | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Hyper IgM Syndrome, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Cancer | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
![]() |
Pre-IND/IDE or Equivalent | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | iPS Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Brain Injury, hypoxic, ischemic | Adult Stem Cell | Donor cell therapy | Sanford-Burnham |
![]() |
Pre-IND/IDE or Equivalent | |
Canavan Disease | iPS Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
IND | |
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
IND | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Hemophilia A | Adult Stem Cell | Gene modification | COH |
![]() |
Development Candidate, Proof of Concept | |
Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Vaccine | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Dementia | iPS Cell | Donor cell therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Development Candidate, Proof of Concept |